Table 1.
Variable | N | % |
---|---|---|
Gender | ||
Male | 27 | 50.9 |
Female | 26 | 49.1 |
Pulmonary impairment | ||
< 10% | 20 | 37.8 |
10–50% | 27 | 50.9 |
> 50% | 6 | 11.3 |
Support O2 | ||
None | 12 | 22.6 |
Nasal catheter | 16 | 30.2 |
Orotracheal intubation | 25 | 47.2 |
Outcome | ||
Discharge | 31 | 58.5 |
Death | 22 | 41.5 |
SOFA score | ||
≤ 9 (mild to moderate) | 32 | 60.4 |
> 9 (severe) | 21 | 39.6 |
Comorbiditiesa | ||
Yes | 52 | 98.1 |
No | 1 | 1.9 |
Total | 53 | 100 |
SOFA = Sequential Organ Failure Assessment Comorbiditiesa | ||
Systemic arterial hypertension—81.1% (43/53) | ||
Diabetes mellitus—45.3%(24/53) | ||
Chronic kidney disease—24.5% (13/53) | ||
Cardiovascular disease—20.8% (11/53) | ||
Pulmonary disease—11.3% (6/53) | ||
Immunodeficiency—11.3% (6/53) | ||
Maglinities—7.5% (4/53) |
aThe patient may have had more than one comorbidity